《大行报告》瑞信下调财险(02328.HK)目标价至6.1元 评级「中性」
瑞信发表报告指,中国财险(02328.HK)业绩符合预期,承保利润按年上升31%,主要来自汽车保险带动,预期汽车保险今年保费收入录低双位数跌幅,因改革导致保费下降,估计汽车综合成本率为97至98%,指前景仍然不明朗。
该行指中国财险於信用保险方面录承保亏损51亿元人民币,去年下半年保费录92%跌幅,预期在改善风险管理下,今年新政策的影响有限。
该行升中国财险2021至2022年每股盈利预期各16及9%,以反映去年表现以及储备为盈利提供缓冲,目标价由6.4元降至6.1元,维持「中性」评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.